Impact BioMedical Inc. (IBO)
4.76
2.68 (128.85%)
At close: Mar 21, 2025, 3:59 PM
4.11
-13.66%
After-hours: Mar 21, 2025, 07:07 PM EDT
128.85% (1D)
| Bid | 4.08 |
| Market Cap | 54.76M |
| Revenue (ttm) | 66.36K |
| Net Income (ttm) | -650.45K |
| EPS (ttm) | 0.1 |
| PE Ratio (ttm) | 47.6 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.1 |
| Volume | 139,833,085 |
| Avg. Volume (20D) | 505,335 |
| Open | 3.16 |
| Previous Close | 2.08 |
| Day's Range | 2.89 - 6.17 |
| 52-Week Range | 0.51 - 6.17 |
| Beta | 7.50 |
About IBO
Impact BioMedical Inc. engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. It provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory an...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 1
Stock Exchange AMEX
Ticker Symbol IBO
Website https://www.impactbiomedinc.com
5 months ago
+19.2%
Impact BioMedical shares are trading higher after ...
Unlock content with
Pro Subscription